President Donald Trump announced Tuesday that imported generic drugs will remain tariff-free for the next two years before facing steep new import duties, saying the move is designed to encourage pharmaceutical companies to manufacture more medicines in the U.S.

The HHS secretary called surveillance cuts 'redundant' and rejected criticism of the administration's response